Catalyst Pharmaceuticals Archives -

Shares in Catalyst Pharmaceuticals have dived after the US regulator approved a potential competitor to its rare disease

Catalyst shares dive amid speculation about ‘off-label’ rare disease rival

https://pharmaphorum.com/news/catalyst-shares-dive-amid-speculation-about-off-label-rare-disease-rival/

Catalyst Pharmaceuticals has defended hiking the price of the rare disease drug Firdapse (amifampridine) from virtually nothing to

Catalyst defends huge US price hike for rare disease drug

https://pharmaphorum.com/news/catalyst-defends-huge-us-price-hike-for-rare-disease-drug/

Already approved in EU, Catalyst aiming for FDA filing next year.

Catalyst to re-submit rare disease drug after trial success

https://pharmaphorum.com/news/catalyst-us-filing-lems-drug/

Catalyst Pharmaceuticals